Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Child Cancer & Rare Disease Project is a specialized biotechnology initiative focused on accelerating the development of treatments for pediatric oncology and orphan diseases. The organization operates by identifying high-potential research from academic institutions and providing the necessary funding and drug development expertise to bridge the gap between discovery and clinical trials. Their portfolio encompasses a variety of modalities, including small molecules and advanced biologics, specifically tailored for childhood-specific indications. By focusing on underserved patient populations, the project aims to de-risk early-stage assets to attract further commercial investment or philanthropic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Child Cancer & Rare Disease Project.